India's Science and Technology Minister, Kapil Sibal, has told a life-science companies conference that, following a significant planned budget increase for biotechnology drug ventures, the government will be ready to enter into R&D partnerships with drugmakers.
Mr Shabil indicated that a formal announcement is due by the end of October, but that he expected a "huge, huge increase" in funding. The Economic Times of India, which reported the Minister's speech, noted that India's biotechnology market is currently worth about $2.0 billion and is expected to reach $5.0 billion by 2010.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze